Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиCue Biopharma Мультипликаторы 2011-2024 | CUE
Мультипликаторы по годам Cue Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.7 | -2.0 | -8.0 | -8.7 | -9.2 | -2.6 | -13.4 | - | - | - | - | - | - |
P/S |
15.8 | 87.0 | 23.7 | 123.1 | 97.3 | 88.5 | - | - | - | - | - | - | - |
EPS |
-1.1 | -1.5 | -1.4 | -1.6 | -1.7 | -1.9 | -2.2 | - | - | - | - | - | - |
EV (Enterprise Value) |
62.4 млн | 82.4 млн | 307 млн | 334 млн | 309 млн | 112 млн | 317 млн | 1.1 млн | 376 тыс. | - | - | - | - |
EBITDA per Share |
-1.13 | -1.47 | -1.36 | -1.53 | -1.43 | -1.88 | -1.11 | - | - | - | - | - | - |
EV/EBITDA |
-7.0 | -7.2 | -9.2 | -2.1 | -11.0 | - | - | - | - | - | - | ||
PEG |
0.2 | -0.2 | - | -1.44 | -0.64 | 0.04 | 0.07 | - | - | - | - | - | - |
P/B |
2.3 | 1.6 | 5.4 | 4.9 | 6.2 | 3.0 | 5.1 | - | - | - | - | - | - |
P/CF |
-2.2 | -2.6 | -9.1 | -11.7 | -10.9 | -3.6 | -23.2 | - | - | - | - | - | - |
ROE % |
-136.80 | -80.71 | -67.43 | -56.75 | -67.23 | -114.74 | -37.71 | - | - | - | - | - | - |
ROA % |
-82.45 | -58.07 | -52.95 | -44.99 | -51.25 | -85.93 | -34.70 | - | - | - | - | - | - |
ROCE % |
-140.62 | -81.03 | -66.74 | -54.13 | -61.33 | -98.85 | -37.71 | - | - | - | - | - | - |
Current Ratio |
2.5 | 3.6 | 4.7 | 5.4 | 5.2 | 6.5 | 12.2 | - | - | - | - | - | - |
DSO |
58.3 | 469.0 | 55.7 | 164.0 | 79.7 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
58.3 | 469.0 | 55.7 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
58.3 | 469.0 | 55.7 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Cue Biopharma
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.24 | -0.29 | -0.29 | - | -0.31 | -0.37 | -0.44 | - | -0.41 | -0.33 | -0.41 | - | -0.34 | -0.38 | -0.48 | - | -0.31 | -0.46 | -0.54 | - | -0.62 | -0.36 | -0.37 | - | -0.47 | -0.41 | -0.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.24 | -0.3 | -0.3 | - | -0.31 | -0.36 | -0.43 | - | -0.39 | -0.32 | -0.4 | - | -0.31 | -0.37 | -0.48 | - | -0.29 | -0.42 | -0.54 | - | -0.62 | -0.36 | -0.37 | - | -0.45 | -0.4 | -0.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-99.86 | -95.65 | -89.09 | -65.73 | -86.18 | -85.05 | -77.05 | -52.50 | -65.21 | -57.47 | -57.10 | -42.68 | -55.49 | -55.58 | -59.30 | -50.89 | -87.84 | -111.98 | -116.02 | -80.58 | -88.75 | -59.97 | -45.64 | -20.77 | -20.77 | -12.60 | -5.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-64.40 | -62.79 | -60.48 | -45.79 | -62.26 | -48.66 | -60.12 | -42.03 | -52.11 | -45.71 | -45.13 | -33.84 | -43.60 | -43.29 | -45.70 | -38.79 | -66.46 | -84.37 | -87.16 | -60.34 | -67.86 | -47.71 | -38.21 | -19.11 | -19.11 | -11.59 | -5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-102.20 | -97.16 | -89.69 | -65.65 | -86.15 | -84.91 | -77.14 | -52.59 | -65.43 | -57.78 | -57.51 | -43.17 | -56.17 | -56.33 | -59.37 | -50.84 | -88.40 | -112.96 | -118.04 | -81.69 | -89.86 | -60.47 | -45.64 | -20.77 | -20.77 | -12.60 | -5.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.6 | 2.7 | 3.1 | 3.6 | 3.0 | - | 3.5 | 4.7 | 5.1 | 5.3 | 4.7 | 4.8 | 4.8 | 4.8 | 4.8 | 4.2 | 4.2 | 4.2 | 4.2 | 4.0 | 4.0 | 4.0 | 4.0 | 12.5 | 12.5 | 1.7 | 12.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
60.8 | 43.9 | 61.7 | - | 534.1 | 1623.2 | 185.6 | - | 51.0 | 55.2 | 83.2 | - | 183.7 | 120.3 | 110.1 | - | 70.0 | 65.3 | 93.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
60.8 | 43.9 | 61.7 | - | 534.1 | 1623.2 | 185.6 | - | 51.0 | 55.2 | 83.2 | - | 183.7 | 120.3 | 110.1 | - | 70.0 | 65.3 | 93.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
60.8 | 43.9 | 61.7 | - | 534.1 | 1623.2 | 185.6 | - | 51.0 | 55.2 | 83.2 | - | 183.7 | 120.3 | 110.1 | - | 70.0 | 65.3 | 93.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD